X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. REDDYS LAB UNICHEM LAB/
DR. REDDYS LAB
 
P/E (TTM) x 29.7 29.7 100.0% View Chart
P/BV x 3.1 2.9 107.4% View Chart
Dividend Yield % 0.6 0.9 65.4%  

Financials

 UNICHEM LAB   DR. REDDYS LAB
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DR. REDDYS LAB
Mar-17
UNICHEM LAB/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3343,397 9.8%   
Low Rs1742,560 6.8%   
Sales per share (Unadj.) Rs146.9856.5 17.2%  
Earnings per share (Unadj.) Rs11.978.0 15.3%  
Cash flow per share (Unadj.) Rs16.2139.9 11.6%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.80.7 117.3%  
Book value per share (Unadj.) Rs105.1739.8 14.2%  
Shares outstanding (eoy) m90.84165.74 54.8%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x1.73.5 49.7%   
Avg P/E ratio x21.438.2 55.9%  
P/CF ratio (eoy) x15.721.3 73.7%  
Price / Book Value ratio x2.44.0 60.0%  
Dividend payout %16.825.7 65.5%   
Avg Mkt Cap Rs m23,073493,632 4.7%   
No. of employees `0005.722.7 25.0%   
Total wages/salary Rs m2,55831,068 8.2%   
Avg. sales/employee Rs Th2,352.56,259.0 37.6%   
Avg. wages/employee Rs Th450.91,369.8 32.9%   
Avg. net profit/employee Rs Th190.4569.7 33.4%   
INCOME DATA
Net Sales Rs m13,346141,961 9.4%  
Other income Rs m1921,715 11.2%   
Total revenues Rs m13,538143,676 9.4%   
Gross profit Rs m1,63924,722 6.6%  
Depreciation Rs m39010,266 3.8%   
Interest Rs m29634 4.5%   
Profit before tax Rs m1,41215,537 9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4349 -1.1%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2932,965 9.9%   
Profit after tax Rs m1,08012,921 8.4%  
Gross profit margin %12.317.4 70.5%  
Effective tax rate %20.719.1 108.6%   
Net profit margin %8.19.1 88.9%  
BALANCE SHEET DATA
Current assets Rs m5,97996,837 6.2%   
Current liabilities Rs m2,43284,199 2.9%   
Net working cap to sales %26.68.9 298.6%  
Current ratio x2.51.2 213.8%  
Inventory Days Days6373 86.0%  
Debtors Days Days6098 61.8%  
Net fixed assets Rs m6,403102,552 6.2%   
Share capital Rs m182829 21.9%   
"Free" reserves Rs m9,293121,792 7.6%   
Net worth Rs m9,548122,621 7.8%   
Long term debt Rs m2305,449 4.2%   
Total assets Rs m12,843218,165 5.9%  
Interest coverage x50.025.5 196.2%   
Debt to equity ratio x00 54.3%  
Sales to assets ratio x1.00.7 159.7%   
Return on assets %8.66.2 139.0%  
Return on equity %11.310.5 107.4%  
Return on capital %14.312.9 111.1%  
Exports to sales %29.254.6 53.5%   
Imports to sales %6.39.4 67.9%   
Exports (fob) Rs m3,90077,520 5.0%   
Imports (cif) Rs m84713,274 6.4%   
Fx inflow Rs m4,35681,670 5.3%   
Fx outflow Rs m1,16226,355 4.4%   
Net fx Rs m3,19455,315 5.8%   
CASH FLOW
From Operations Rs m1,11921,444 5.2%  
From Investments Rs m-853-18,404 4.6%  
From Financial Activity Rs m-334-3,692 9.1%  
Net Cashflow Rs m-68-1,144 6.0%  

Share Holding

Indian Promoters % 50.1 25.5 196.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 5.4 279.6%  
FIIs % 3.0 35.3 8.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 31.7 15.3 207.2%  
Shareholders   20,176 75,885 26.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA  STRIDES SHASUN LTD  FDC LTD.  NATCO PHARMA  DISHMAN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of PNB Fraud, Rising Troubles at PSBs, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 236 points and the NSE Nifty closed down by 74 points.

Related Views on News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS